经乳晕切口治疗聚丙烯酰胺水凝胶注射隆乳术后并发症(1)
 |
| 第1页 |
参见附件(1947KB，3页)。
[摘要]目的：探讨聚丙烯酰胺水凝胶(PAHG)注射隆乳术后并发症及治疗方法。方法：自2003年7月～2009年5月，我科共收治PAHG注射隆乳术后患者67例，年龄32～50岁，均为双侧注射，术前常规行乳腺彩超和MRI检查，明确注射层次和周围组织浸润等情况。术中采用乳晕下缘切口，直视下取出注射物，根据肌肉的完整程度、有无感染以及注射物残留情况决定是否进行Ⅰ期乳房假体置入手术，其中有28例患者Ⅰ期置入乳房假体。结果：本组患者随访6个月～2年，所有患者术前症状基本消失，无假体疝出、感染、切口裂开、双侧乳房不对称等并发症出现，治疗效果良好。结论：经乳晕切口行PAHG取出术可最大程度的取出注射物，可在直视下了解周围组织破坏程度，决定乳房假体置入时机，可取得良好的治疗效果。
[关键词]聚丙烯酰胺水凝胶；隆乳术；并发症
[中图分类号]R622[文献标识码]A[文章编号]1008-6455(2011)09-1359-03
The periareolar approach management of postoperative complication of breast augmentation by injected polyacrylamide hydrophilic gel
LI Wei,LIU Chang-song,WANG Tao,CHEN Wei-hua
(The Plastic And Cosmetic And Laser Center,The Fourth Affiliated Hospital of HRB Medical University,Haerbin 150001,Heilongjiang,China)
Abstract:ObjectiveTo investigate postoperative complications of breast augmentation by injected polyacrylamide hydrophilic gel(PAHG) and discuss treatment through the periareolar approach.MethodsFrom July 2003 to May 2009，67 patients with bilateral breast augmentation by injected PAHG underwent operation in our department, The age of patients ranged from 32 to 50 years.Ultrasound and MRl were performed before operation to show the distribution of PAHG and the tissue infiltration around the PAHG.The fillers were removed under direct vision through the periareolar approach.According to the muscle integrity, infection and PAHG residue，whether breast implants were implanted at the same stage was determined，and the breast implantation operation were performed in 28 patients.ResultsThe patients were followed up for 6 months to 2 years.The symptoms before operation disappeared in all patients , there was no complication of implant hernia，infection，wound disruption，or asymmetry.ConclusionsThe PAHG can be removed mostly and the degree of histoclasia can be known under direct vision,and the time for breast implantion can be determined , satisfactory results can be achieved.
Key words:polyacrylamide hydrophilic gel；augmentation mammoplasty；complication
聚丙烯酰胺水凝胶于1997年在我国开始应用，由于手术创伤小，易被患者接受，曾一度被广泛应用于注射隆乳，随着受术者日益增多，并发症亦逐渐暴露出来，近年来关于聚丙烯酰胺水凝胶注射隆乳术后引发并发症的报道较多[1-8]，因此，其已被禁止作为软组织充填材料应用于临床。但先前注射隆乳后所致的相当多的并发症在今后相当长的一段时间仍需妥善处理，尤其是注射物取出术后所遗留的继发畸形，成了目前关注的焦点。我科自2003年7月～2009年5月，共收治67例应用PAHG注射隆乳引起不同并发症的患者 ......
您现在查看是摘要介绍页，详见PDF附件(1947KB，3页)。